We would love to hear your thoughts about our site and services, please take our survey here.
Great update and proactive interview Gerry. Well done to yourself and all the team. Looks like every part of the business is growing rapidly, launch of Skin Trust Medical sounds exciting and more news to come this week or next.
Retire, you really can not refrain from insults can you. I am all too aware of Microtox's involvement in the Olympics as I do my research and read RNSs. My point was merely to state that this year DVRG will clearly benefit from the Microtox installations, having acquired Modern water.
I think what is important is the fact that the Microtox technology is being used for water screening at the Olympics - a huge endorsement. The technical differences between the PD units and other units are really neither here nor there.
Gerry's tweet seems pretty clear to me. If you feel so strongly sell up and leave. Being rude achieves nothing accept reflecting badly on the person dishing it out.
When you consider the hoops AGL has had to jump through before commercialisation of its proven Parsortix technology can begin you do wonder how the convicted and disgraced Elizabeth Holmes ever got her failed 'Edison' blood testing machine off the ground. Clearly no testing of the machine was ever properly conducted, certainly no clinical trials or FDA approval and yet hundreds of millions of dollars were invested in her company and commercialisation and usage of the device was permitted. Very strange.
2021 has been a year of substantial progress for DVRG and full credit to Gerry and the team for making it so. The sp sadly does not the reflect this as poor market sentiment towards small cap stocks since June has weighted heavily on the sp of many companies including DVRG. To the astute investor however this now represents a fantastic buying opportunity. DVRG has positioned itself as one a very few life science and environmental health companies with a transformational technology with its ability to monitor in real time pathogens in waste water. DVRG has a substantial global footprint and will next year be rolling out in mass its transformational microtox PD technology across several continents, including China, as well as partnering with China Resources, a company on a par with Pfizer in size. It's Microtox BT breathalyser for the rapid and highly accurate detection of Sars-Cov-2 and other pathogens in humans will similarly be rolled out pending a CE mark. Labskin continues to expand at a phenomenal pace. And then there is Skin Trust Club, launched only months ago but already expanding globally and revolutionising skin care treatment to customers whilst providing skin care manufacturers the data needed to conduct clinical trials - the perfect circle of data utilisation.
DVRG is one of the gems to watch out for in 2022. Don't get left behind.
It's the microtox BT breath test devices you need for the cruise ships, not the PD ones, but they haven't completed the human trials yet.
Best wishes and a very merry Christmas to you too Gerry. I would say most of us shareholders on this board really appreciate your efforts and all your team's hard work throughout the year, and realise that it takes time to really build value in a small cap company. I'm very much looking forward to what I believe will be a transformational year next year for Deepverge.
Zzzzzzzzzzzzzzzzzzzzzzzz!!!
He's posting because he has an obsession with DVRG for some reason. He does not post about any other company. Look at his profile. Plenty of AIM companies are down this year since the small cap sell off in June and yet not a word about any of them. Why is that I wonder?? Does it not make you question Doggin's motives? DVRG's share price has been held back as a result of poor market sentiment in the small cap space at present. There has been plenty of progress at DVRG. Just have to read the RNSs and listen to the presentations.
You're getting a bit desperate now with your rants! Worried the mask is beginning to slip? Just give up. Nobody believes you anymore.
Congratulations to Cathal and all the team on another substantial contract win. That's now £40 million worth of contracts since August. A phenomenal achievement.
What a shame Muggins is incapable of reading RNSs, listening to podcasts and presentations and generally keeping up with events. I think he has been asleep at the wheel for the best part of 2021. Best you sell and move on. DVRG is clearly not for you. But then again looking at your profile neither is any other company.
Well done Gerry to you and all your team. This is fantastic news.
Short, Gerry doesn't have to explain anything to you or anyone else. He is already extremely communicative and the most engaging of CEOs I can think of. If you cared to take the time to read the RNSs and listened to Gerry's interviews instead of being rude you would know exactly what the status of things was. It takes time to process contracts but that does not mean they are not in the pipeline. So much has already been achieved this year for which the revenues will be recognised next year.
Hugely exciting period for OO.
.Revenue guidance £40m for 2021 and now EBITDA profitable.
.Revenue guidance of at least £50m for 2022 not including potential £40m Gov covid contract.
Targeting increased margins to above 30%.
.Poolbeg massive value add as its assets are built up and gradually monetised.
.DIM spinout early next year which will involve selling to multibillion dollar wearable companies and selling algorithms to multibillion pharma companies to speed up their clinical trials.
.Spinout out of Imutex and Prep Bio.
.Imutex previous valuations were not factoring in successful phase 1 malaria vaccine results.
.Management with huge skin in the game and interests aligned with shareholders.
Everything to play for. Currently massive disconnect between the sp and overall value.
The sp does not really attribute any value to the non-core assets at present which is ludicrous. How many profitable fast-growing companies listed on AIM are offering free shares in 4 newly listed companies?
2022 should be hugely exciting for OO shareholders.
Great news and much needed. Congratulations to Cathal and all the team.
GB twitter message - So many multi-year long missions in @Labskin,@skintrustclub @Modern_Water and across the @DeepVerge Group, with multi-partners coming to a head at close to the same time. Great moments to be involved in this amazing team effort.
Thanks Ken. Another reassuring interview by Cathal and Jeremy. Plenty of positive newsflow over the coming months. Clearly Poolbeg could be huge in its own right although it's only one of four spinouts to come. Bring on 2022!
Another great interview by GB on proactive in which he highlights not only the progress and opportunities for the company but also the massive environmental problem of 'forever chemicals'. DVRG is definitely in the right place at the right time.